Bar-Eli M, Wilson L, Peters R S, Schwabe A D, Territo M C
Am J Med Sci. 1982 Sep-Oct;284(2):2-7. doi: 10.1097/00000441-198209000-00001.
Polymorphonuclear (PMN) cells derived from patients with Familial Mediterranean Fever (FMF) were evaluated in vitro for the function and concentration of their microtubules. Using the time-decay colchicine binding assay to determine the tubulin concentration in PMN cells, no difference was found in PMN cells derived from FMF patients in comparison with those from normal healthy subjects. Colchicine treatment had no effect on the detectable tubulin concentration in the cells. The mobility of fluorescent con A(F-con A)-receptor complexes on PMN membranes was used to test the function of the microtubules. PMNs from untreated FMF patients showed the same pattern of con A cap formation as seen in normal cells. PMNs derived from colchicine treated patients, however, showed 22-32% spontaneous cap formation. These cells also showed 10-30% more capping in comparison with normal or untreated FMF cells, for any given in vitro colchicine concentration, suggesting that at therapeutic doses, the colchicine does accumulate in the PMNs in vivo. We were unable to demonstrate a microtubule defect in the neutrophils from FMF patients in these studies.
对来自家族性地中海热(FMF)患者的多形核(PMN)细胞进行了体外微管功能和浓度评估。使用时间衰减秋水仙碱结合试验来测定PMN细胞中的微管蛋白浓度,结果发现FMF患者的PMN细胞与正常健康受试者的PMN细胞相比没有差异。秋水仙碱处理对细胞中可检测到的微管蛋白浓度没有影响。利用荧光刀豆球蛋白A(F-con A)-受体复合物在PMN膜上的移动性来测试微管的功能。未经治疗的FMF患者的PMN显示出与正常细胞中所见相同的刀豆球蛋白A帽形成模式。然而,来自秋水仙碱治疗患者的PMN显示出22%-32%的自发帽形成。对于任何给定的体外秋水仙碱浓度,这些细胞与正常或未经治疗的FMF细胞相比,帽形成也多10%-30%,这表明在治疗剂量下,秋水仙碱确实会在体内PMN中蓄积。在这些研究中,我们未能证明FMF患者中性粒细胞存在微管缺陷。